Angiogenesis and epidermal growth factor receptor inhibitors in non-small cell lung cancer

Several preclinical studies suggested a potential benefit from combined treatment with inhibitors of epidermal growth factor receptor (EGFR) and angiogenesis, both effective in patients with advanced non-small-cell lung cancer (NSCLC). In pretreated patients with advanced EGFR wild type NSCLC, bevac...

Descripción completa

Detalles Bibliográficos
Autores principales: Palumbo, Giuliano, Esposito, Giovanna, Carillio, Guido, Manzo, Anna, Montanino, Agnese, Sforza, Vincenzo, Costanzo, Raffaele, Sandomenico, Claudia, La Manna, Carmine, Martucci, Nicola, La Rocca, Antonello, De Luca, Giuseppe, Piccirillo, Maria Carmela, De Cecio, Rossella, Perrone, Francesco, Totaro, Giuseppe, Muto, Paolo, Picone, Carmine, Normanno, Nicola, Morabito, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Open Exploration 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9400697/
https://www.ncbi.nlm.nih.gov/pubmed/36046069
http://dx.doi.org/10.37349/etat.2020.00008

Ejemplares similares

Ejemplares similares